(Q35204851)

7 August 2017

1 reference

title

The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis (English)

1 reference

7 August 2017

main subject

endocannabinoid system

0 references

0 references

0 references

1 reference

M Maccarrone

1

1 reference

7 August 2017

A Finazzi-Agró

series ordinal

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Cell Death & Differentiation

7 August 2017

published in

1 reference

7 August 2017

volume

10

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

946-955

1 reference

CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Cannabinoids and brain injury: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Endocannabinoids and their actions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Cannabinoid receptors and pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Neurobiology Cannabinoids act backwards

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The fatty acid amide hydrolase (FAAH).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Molecular probes for the cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Molecular basis for species-specific sensitivity to "hot" chili peppers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Anandamide: some like it hot.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Δ9 -Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The evolution of diverse biological responses to DNA damage: insights from yeast and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Neurotrophins: the biological paradox of survival factors eliciting apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The endogenous cannabinoid system and brain development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Targeting the endocannabinoid system in cancer therapy: a call for further research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401284

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401284

1 reference

Dimensions Publication ID

7 August 2017

1033984204

0 references

1 reference